Focus: Vivos Therapeutics develops oral appliance technology for sleep apnea and related respiratory conditions. The company operates as a specialized medical device biotech focused on a narrow but clinically significant therapeutic area.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Vivos is a niche device-focused biotech best suited for candidates seeking specialized sleep medicine/respiratory expertise in a small, focused environment with limited near-term growth signals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Vivos Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Vivos Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Price to book forward of Vivos Therapeutics, Inc. – NASDAQ:VVOS - TradingView
Price to book forward of Vivos Therapeutics, Inc. – NASDAQ:VVOS TradingView
Vivos Therapeutics Inc (VVOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vivos Therapeutics Inc (VVOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey
VVOS|Vivos Therapeutics Inc|Price:0.406|Chg%:-0.008 - TradingKey
VVOS|Vivos Therapeutics Inc|Price:0.406|Chg%:-0.008 TradingKey
Vivos Therapeutics Inc (VVOS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vivos Therapeutics Inc (VVOS) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey
Vivos Therapeutics Inc (VVOS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivos Therapeutics Inc (VVOS) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey
Vivos Therapeutics Inc (VVOS) Institutional Confidence - TradingKey
Vivos Therapeutics Inc (VVOS) Institutional Confidence TradingKey
Showing 6 of 10 news items
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles